Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIR22HG
   Synonyms MIR22HG, C17orf91, MGC14376, DKFZp686O06159
   Region GRCh38_17:1711493-1717174    Sequence
   Ensembl ENSG00000186594
   RefSeq NR_028502
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name lung cancer
   ICD-0-3 C34  
   Methods qPCR etc.
   Sample lung cancer tissues, cell lines (PC-9, H1975, H1299, H838 and H2228)
   Expression Pattern down-regulated
   Function Description

MIR22HG was significantly downregulated in lung cancer;this decreased expression was associated with poor patient survival. MIR22HG bound and stabilized the YBX1 protein.Silencing of MIR22HG triggered both cell survival and cell death signaling through dysregulation of the oncogenes YBX1,MET,and p21. In this MIR22HG network,p21 played an oncogenic role by promoting cell proliferation and anti-apoptosis in lung cancers.MIR22HG played a tumor suppressor role as indicated by inhibition of multiple cell cycle-related genes in human primary lung tumors.

   Pubmed ID 29669758
   Year 2018
   Title Silencing of long non-coding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer.
   External Links
   Links for  MIR22HG GenBank       HGNC       lncrnadb       Noncode
   Links for  lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.